|
|
|
|
LEADER |
01710nam a22003015i 4500 |
001 |
000279611 |
005 |
20211026114558.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387723792
|
024 |
7 |
|
|a 10.1007/978-0-387-72379-2
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Biopharmaceutics Applications in Drug Development /
|c edited by Rajesh Krishna, Lawrence Yu.
|
250 |
|
|
|a 1st ed. 2008.
|
260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2008.
|
300 |
|
|
|a XXII, 396 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a to Biopharmaceutics and its Role in Drug Development -- Molecular and Physicochemical Properties Impacting OralAbsorptionofDrugs -- Dissolution Testing -- Drug Absorption Principles -- Evaluation of Permeability and P-glycoprotein Interactions: Industry Outlook -- Excipients as Absorption Enhancers -- IntestinalTransporters in Drug Absorption -- Bioavailability and Bioequivalence -- A Biopharmaceutical Classification System Approach to Dissolution: Mechanisms and Strategies -- Food Effects on Drug Bioavailability: Implications for New and Generic Drug Development -- In Vitro–In Vivo Correlation on Parenteral Dosage Forms -- In Vitro–In Vivo Correlation in Dosage Form Development: Case Studies.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Biochemistry.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Biochemistry, general.
|
700 |
1 |
|
|a Krishna, Rajesh.
|e editor.
|
700 |
1 |
|
|a Yu, Lawrence.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|